ArticleACS applied polymer materials2024
Probing the Solubility of Imine-Based Covalent Adaptable Networks.
Article in ACS applied polymer materials, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Interpenetrating Dual Epoxy Networks with Reversible Covalent Bonds: Shape-Constant Self-Healing Electrically Insulating Materials.ACS applied polymer materials · 2026Article
- Dynamic Imine-Linked NIPU with Shape Memory, Self-Healing, and Prospects for Recyclability.Polymers · 2026Article
- Mechanochemical Synthesis of Recyclable Biohybrid Polymer Networks Using Whole Biomass.Angewandte Chemie (International ed. in English) · 2025Article
- Biobased Polyimine Vitrimers: Promising Materials for Fluorescence Quenching, Anticounterfeiting, and Plastic Degradation.ACS omega · 2025Article
- Chemical and Solvent-Based Recycling of DGEBA-Based Epoxy Thermoset and Carbon-Fiber Reinforced Epoxy Composite Utilizing Imine-Containing Secondary Amine Hardener.Macromolecular rapid communications · 2025Article
- Dynamic Covalent Bond-Based Polymer Chains Operating Reversibly with Temperature Changes.Molecules (Basel, Switzerland) · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Covalent adaptable networks (CANs) are polymer materials that are covalently cross-linked via dynamic covalent bonds. The cross-linked polymer network is generally expected to be insoluble, as is seen for traditional thermosets. However, in recent years, it has become apparent that-under certain conditions-both dissociative and associative CANs can be dissolved in a good solvent. For some applications (e.g., those that require long-term (chemical) stability), the solubility of CANs can be problematic. However, many forget that (selective) solubility of CANs can also be applied advantageously, for example, in recycling or modification of the materials. In this work, we provide results and insights related to the tunable solubility of imine-based CANs. We observed that selected CANs could be fully dissolved in a good solvent without observing dissociation of imines. Only in an acidic environment (partial) dissociation of imines was observed, which could be reverted to the associated state by addition of a base. By adjusting the network composition, we were able to either facilitate or hamper solubility as well as control the size of the dissolved particles. DLS showed that the size of dissolved polymer particles decreased at lower concentrations. Similarly, decreasing cross-linking density resulted in smaller particles. Last, we showed that we could use the solubility of the CANs as a means for chemical recycling and postpolymerization modification. The combination of our studies with existing literature provides a better understanding of the solubility of CANs and their applications as recyclable thermosets.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.